Switch to:
Also traded in: Argentina, Germany, Mexico

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.23
CAH's Cash-to-Debt is ranked lower than
78% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.69 vs. CAH: 0.23 )
Ranked among companies with meaningful Cash-to-Debt only.
CAH' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.42 Max: 3.34
Current: 0.23
0
3.34
Equity-to-Asset 0.15
CAH's Equity-to-Asset is ranked lower than
91% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.44 vs. CAH: 0.15 )
Ranked among companies with meaningful Equity-to-Asset only.
CAH' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.15  Med: 0.35 Max: 0.5
Current: 0.15
0.15
0.5
Debt-to-Equity 1.52
CAH's Debt-to-Equity is ranked lower than
84% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.56 vs. CAH: 1.52 )
Ranked among companies with meaningful Debt-to-Equity only.
CAH' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.04  Med: 0.46 Max: 1.53
Current: 1.52
0.04
1.53
Debt-to-EBITDA 3.15
CAH's Debt-to-EBITDA is ranked lower than
75% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.37 vs. CAH: 3.15 )
Ranked among companies with meaningful Debt-to-EBITDA only.
CAH' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.22  Med: 1.68 Max: 3.51
Current: 3.15
0.22
3.51
Interest Coverage 5.55
CAH's Interest Coverage is ranked lower than
67% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.71 vs. CAH: 5.55 )
Ranked among companies with meaningful Interest Coverage only.
CAH' s Interest Coverage Range Over the Past 10 Years
Min: 5.71  Med: 14.03 Max: 19.27
Current: 5.55
5.71
19.27
Piotroski F-Score: 7
Altman Z-Score: 4.04
Beneish M-Score: -2.63
WACC vs ROIC
6.09%
27.71%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 1.30
CAH's Operating Margin % is ranked lower than
69% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.60 vs. CAH: 1.30 )
Ranked among companies with meaningful Operating Margin % only.
CAH' s Operating Margin % Range Over the Past 10 Years
Min: 1.37  Med: 1.71 Max: 2.14
Current: 1.3
1.37
2.14
Net Margin % 0.53
CAH's Net Margin % is ranked lower than
59% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.61 vs. CAH: 0.53 )
Ranked among companies with meaningful Net Margin % only.
CAH' s Net Margin % Range Over the Past 10 Years
Min: 0.19  Med: 0.99 Max: 1.28
Current: 0.53
0.19
1.28
ROE % 10.88
CAH's ROE % is ranked higher than
90% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.39 vs. CAH: 10.88 )
Ranked among companies with meaningful ROE % only.
CAH' s ROE % Range Over the Past 10 Years
Min: 3.98  Med: 17.46 Max: 22.28
Current: 10.88
3.98
22.28
ROA % 1.79
CAH's ROA % is ranked higher than
59% of the 59 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.37 vs. CAH: 1.79 )
Ranked among companies with meaningful ROA % only.
CAH' s ROA % Range Over the Past 10 Years
Min: 0.64  Med: 4.39 Max: 4.74
Current: 1.79
0.64
4.74
ROC (Joel Greenblatt) % 53.38
CAH's ROC (Joel Greenblatt) % is ranked higher than
83% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.92 vs. CAH: 53.38 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
CAH' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 21.1  Med: 62.14 Max: 122.97
Current: 53.38
21.1
122.97
3-Year Revenue Growth Rate 12.40
CAH's 3-Year Revenue Growth Rate is ranked higher than
70% of the 47 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.70 vs. CAH: 12.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
CAH' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -4.7  Med: 13.2 Max: 43.9
Current: 12.4
-4.7
43.9
3-Year EBITDA Growth Rate 5.40
CAH's 3-Year EBITDA Growth Rate is ranked higher than
54% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 8.60 vs. CAH: 5.40 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
CAH' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -10.3  Med: 10.4 Max: 84.5
Current: 5.4
-10.3
84.5
3-Year EPS without NRI Growth Rate -39.20
CAH's 3-Year EPS without NRI Growth Rate is ranked higher than
50% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 6.10 vs. CAH: -39.20 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
CAH' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -39.2  Med: 9.4 Max: 64.5
Current: -39.2
-39.2
64.5
GuruFocus has detected 2 Warning Signs with Cardinal Health Inc CAH.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» CAH's 30-Y Financials

Financials (Next Earnings Date: 2019-02-07 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q4 2017

CAH Guru Trades in Q4 2017

Joel Greenblatt 277,754 sh (New)
Jim Simons 77,900 sh (New)
Pioneer Investments 1,827,056 sh (New)
Larry Robbins 751,018 sh (New)
Ray Dalio 475,692 sh (New)
Seth Klarman 5,100,000 sh (+101.58%)
Charles Brandes 1,252,911 sh (+79.36%)
John Rogers 861,809 sh (+17.14%)
Richard Pzena 1,950,460 sh (+7.97%)
John Buckingham 22,478 sh (+4.61%)
Steven Cohen 51,400 sh (unchged)
Paul Tudor Jones Sold Out
First Pacific Advisors Sold Out
Vanguard Health Care Fund 7,572,246 sh (-3.73%)
David Dreman 590 sh (-95.18%)
Steven Cohen 316,500 sh (-64.07%)
Mairs and Power 3,344 sh (-2.62%)
Barrow, Hanley, Mewhinney & Strauss 17,876,233 sh (-10.85%)
» More
Q1 2018

CAH Guru Trades in Q1 2018

Richard Pzena 2,873,639 sh (+47.33%)
Steven Cohen 1,266,327 sh (+300.10%)
Barrow, Hanley, Mewhinney & Strauss 18,582,776 sh (+3.95%)
Larry Robbins 3,016,195 sh (+301.61%)
Ray Dalio 606,782 sh (+27.56%)
David Dreman 590 sh (unchged)
Seth Klarman 5,100,000 sh (unchged)
Joel Greenblatt Sold Out
Jim Simons Sold Out
Vanguard Health Care Fund 6,936,246 sh (-8.40%)
Charles Brandes 1,204,802 sh (-3.84%)
John Rogers 850,845 sh (-1.27%)
John Buckingham 22,377 sh (-0.45%)
Mairs and Power 3,244 sh (-2.99%)
Pioneer Investments 1,787,229 sh (-2.18%)
» More
Q2 2018

CAH Guru Trades in Q2 2018

Joel Greenblatt 574,383 sh (New)
Paul Tudor Jones 18,467 sh (New)
Jim Simons 356,400 sh (New)
Charles Brandes 1,968,288 sh (+63.37%)
John Rogers 930,324 sh (+9.34%)
Richard Pzena 2,932,134 sh (+2.04%)
Pioneer Investments 2,027,302 sh (+13.43%)
Ray Dalio 752,906 sh (+24.08%)
Seth Klarman 5,100,000 sh (unchged)
Steven Cohen Sold Out
Mairs and Power Sold Out
Larry Robbins Sold Out
Vanguard Health Care Fund 6,818,446 sh (-1.70%)
John Buckingham 19,481 sh (-12.94%)
Barrow, Hanley, Mewhinney & Strauss 17,802,493 sh (-4.20%)
» More
Q3 2018

CAH Guru Trades in Q3 2018

Charles Brandes 2,025,742 sh (+2.92%)
Jim Simons 2,535,800 sh (+611.50%)
John Buckingham 24,775 sh (+27.18%)
Vanguard Health Care Fund 6,818,446 sh (unchged)
Paul Tudor Jones Sold Out
Richard Pzena 2,595,962 sh (-11.47%)
Barrow, Hanley, Mewhinney & Strauss 17,787,608 sh (-0.08%)
Ray Dalio 178,549 sh (-76.29%)
John Rogers 927,657 sh (-0.29%)
Pioneer Investments 306,353 sh (-84.89%)
Joel Greenblatt 436,325 sh (-24.04%)
Seth Klarman 4,738,485 sh (-7.09%)
» More
» Details

Insider Trades

Latest Guru Trades with NYSE:CAH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

Guru Date Action
Impact Price Range
(Average)*
Change from Average Comment Current Shares
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}